Tylenol with Codeine (acetaminophen plus codeine phosphate) clears from the bloodstream within roughly 12 to 16 hours after a single dose, but traces can show up on a urine drug test for one to two days, in oral fluid for up to 21 hours, and in hair for months. The two active ingredients leave the body at similar rates but are detected by different testing methods for very different windows, and your individual genetics can shift those timelines considerably.
How Your Body Handles Each Ingredient
Tylenol with Codeine is really two drugs in one tablet. Acetaminophen (the Tylenol part) is processed mainly by the liver into inactive compounds that get flushed out through the kidneys. Its elimination half-life hovers around two to three hours, meaning that after each half-life period, roughly half the remaining drug has been cleared.
Codeine follows a more complicated path. It is converted in the liver into several metabolites, the most important being morphine. That conversion is handled almost exclusively by a liver enzyme called CYP2D6. The morphine produced is what provides most of the pain relief. Codeine itself has a half-life of about 2.4 to 3.5 hours after a standard oral dose.
Because both ingredients have half-lives in the same general range, most of the drug’s pain-relieving activity fades within four to six hours of a dose. But “no longer working” and “no longer detectable” are two very different things. Metabolites linger in body fluids and tissues long after you stop feeling any effect, and those metabolites are what drug tests look for.
Detection in Blood and Plasma
Blood tests offer the shortest detection window. After a standard therapeutic dose of codeine combined with acetaminophen, peak codeine concentrations in plasma appear within about an hour. In one study using a 60-mg codeine dose paired with acetaminophen, the average peak plasma codeine concentration was about 138 ng/mL, and the elimination half-life was around 2.4 hours. By roughly 12 to 16 hours after a single dose, codeine plasma levels typically fall below the threshold of standard assays.
Acetaminophen clears from the blood on a similar schedule. Across multiple formulations tested in healthy volunteers, its mean elimination half-life ranged from about 1.9 to 2.8 hours, with no significant differences between formulations. Within 12 hours of a single dose, plasma acetaminophen is generally undetectable by routine methods.
Blood testing is uncommon outside of hospitals and forensic investigations because the detection window is so narrow. If you are being tested for workplace or legal purposes, the test almost certainly involves urine, oral fluid, or hair.
Urine Testing and What It Actually Measures
Standard urine drug panels screen for opiates as a class, and codeine triggers that screen. After a dose, codeine and its metabolites are rapidly excreted, with the bulk of the drug showing up in the first 24 hours. In a controlled study with 60-mg and 120-mg intramuscular codeine doses, codeine was detectable in urine throughout a 40-hour collection period at concentrations above 10 ng/mL. Peak urine codeine concentrations appeared at two to five hours and ranged widely, from about 1,475 to over 61,000 ng/mL.
Here is where timing gets tricky. Federal workplace drug testing historically used a 300 ng/mL cutoff for opiates in urine. At that threshold, a single therapeutic dose can produce a positive result for roughly 24 to 48 hours. However, the detection window depends on the cutoff concentration the lab uses, the dose taken, your hydration, and your individual metabolism. Confirmatory testing with GC/MS or LC-MS/MS can distinguish codeine from other opiates and typically looks for specific metabolites.
One important detail: the ratio of codeine to morphine in urine shifts over time. Early on, the codeine-to-morphine ratio is well above 1.0, which tells the lab you took codeine rather than morphine. But late in the elimination phase, that ratio can drop below 1.0, which means a sample collected at the tail end of excretion could look, at first glance, like morphine exposure rather than codeine use. Researchers have found that in some individuals, total morphine exceeded codeine during terminal elimination, even crossing the reporting threshold while codeine had already fallen below it. This makes urine codeine-to-morphine ratios unreliable as the sole marker for distinguishing the two drugs.
Oral Fluid and Saliva Testing
Saliva-based testing has become more common in roadside screening and some workplace programs because collection is easy and observed, reducing the chance of tampering. After a single oral dose of codeine, the mean detection time in oral fluid was about 21 hours when labs used a low cutoff of 2.5 micrograms per liter. At the higher cutoff proposed by federal guidelines (40 micrograms per liter), detection time shrank to roughly seven hours.
One thing researchers noted is that oral fluid codeine concentrations are highly variable between individuals, so a saliva test is useful for detecting recent exposure but not for predicting what someone’s blood level is at that moment. In practical terms, if you took Tylenol with Codeine within the past day, a saliva test could flag it, especially with a sensitive cutoff.
Hair Testing and Long-Term Detection
Hair testing operates on an entirely different timescale. Drugs get incorporated into the hair shaft as it grows, creating a record of past exposure that can stretch back months. In a controlled study, codeine was found in the closest-to-scalp centimeter of hair within 30 minutes of a single 120-mg dose. The more distant portions of the hair shaft did not show codeine until about three weeks later, reflecting the time it takes for a newly grown segment to emerge from the follicle.
After a single 120-mg dose, codeine was still detectable in hair for at least 10 weeks. Following a short multi-day regimen of 30 mg three times daily for five days, hair codeine concentrations were higher and persisted even longer. In people with a history of heavier opioid use, traces of codeine and morphine remained in newly growing hair for months after cessation. After two months of abstinence, about 27 percent of users in one study still tested positive. By four months, 20 percent were positive, though at six months everyone tested negative.
Hair color matters, too. Research has shown that codeine incorporation into hair depends on melanin content, meaning darker hair tends to retain higher drug concentrations than lighter hair, even at equivalent doses. This raises fairness questions for hair-based drug testing, since two people taking the same amount of Tylenol with Codeine might produce quite different hair test results based on hair pigment alone.
Why Your Genetics Can Change Everything
The enzyme CYP2D6 is the bottleneck for converting codeine into morphine, and this enzyme varies dramatically from person to person based on genetics. People fall into several broad categories depending on how many working copies of the CYP2D6 gene they carry.
If you are what pharmacologists call an ultrarapid metabolizer, you convert codeine into morphine faster and more completely than average. In one study, ultrarapid metabolizers had about 50 percent higher plasma morphine concentrations than normal metabolizers after the same codeine dose, and over 90 percent reported feeling sedated compared with half of normal metabolizers. A separate modeling study estimated that ultrarapid metabolizers had 218 percent higher overall morphine exposure than normal metabolizers.
On the other end of the spectrum, poor metabolizers barely convert codeine into morphine at all. Their morphine exposure was dramatically lower than normal metabolizers. For these individuals, codeine provides little to no pain relief because the active metabolite simply is not produced in meaningful amounts.
This genetic variability does not just affect how well the drug works. It also changes how long morphine metabolites linger in the body. An ultrarapid metabolizer who produces a flood of morphine will have morphine-derived metabolites circulating and excreting for longer than a poor metabolizer who produces almost none. The practical consequence: two people taking the same Tylenol with Codeine prescription could have meaningfully different detection windows on a drug test, entirely because of their DNA.
Liver Disease Slows Everything Down
Because both acetaminophen and codeine depend heavily on the liver for processing, liver impairment can extend the time each drug spends in the body. For acetaminophen, the pharmacokinetic profile changes in people with severe liver disease, though short-term use at reduced doses (capped at about 2 grams per day) appears safe in non-alcoholic liver disease. For codeine, the concern goes in two directions: the drug may sit around longer because the liver cannot clear it efficiently, and it may produce less morphine because the conversion enzyme is not working well, potentially reducing pain relief while paradoxically increasing exposure to codeine itself.
Patients with cirrhosis face additional risk because low albumin levels, common in advanced liver disease, leave more free drug circulating in the bloodstream. For this reason, immediate-release formulations are generally preferred over extended-release opioids in liver-impaired patients, since the former are easier to dose-adjust and carry less risk of prolonged toxicity.
Kidney impairment matters too, though this is less well-studied for codeine specifically. Since both acetaminophen and codeine metabolites are ultimately eliminated through the kidneys, reduced kidney function can extend the detection window by slowing excretion of metabolites into the urine.
Drug Interactions That Alter the Timeline
Several common medications can change how fast your body clears codeine by interfering with CYP2D6. A medication that inhibits this enzyme essentially turns you into a poor metabolizer, even if your genetics say otherwise. Well-known CYP2D6 inhibitors include certain antidepressants (fluoxetine, paroxetine, bupropion), the antihistamine diphenhydramine, and some heart medications like quinidine.
When CYP2D6 is blocked, codeine hangs around longer in its unmetabolized form, you get less morphine production and less pain relief, and the pattern of metabolites in your urine may shift in ways that confuse drug-test interpretation. Conversely, enzyme inducers (less common for CYP2D6 specifically, but relevant for other pathways involved in acetaminophen metabolism) could theoretically speed clearance. Researchers have described these drug-drug-gene interactions as capable of changing a person’s effective metabolizer status, with consequences ranging from treatment failure to unexpected toxicity.
Poppy Seeds, False Positives, and Testing Surprises
If you recently ate a poppy seed bagel and then took a urine drug test, the test might flag you for opiates even without any medication in your system. Poppy seeds naturally contain morphine and codeine. In a controlled study where volunteers consumed poppy seeds with known opiate content, over 20 percent of urine specimens exceeded the 300 ng/mL cutoff for codeine, with peak codeine concentrations reaching as high as 658 micrograms per liter (and in some cases much higher). This is a real source of confusion for anyone trying to interpret a positive opiate result.
Beyond poppy seeds, the initial immunoassay screening used in most drug-testing programs has inherent limitations. These tests rely on antibodies that can cross-react with structurally similar compounds, leading to false-positive findings. A positive screen for opiates needs confirmatory testing to be meaningful, and labs that skip that step risk incorrect interpretations with serious consequences for employment, medical care, and legal proceedings.
Hydrocodone as an Unexpected Metabolite
One of the stranger quirks of codeine metabolism is that your body can produce small amounts of hydrocodone from codeine, even if you have never taken hydrocodone. In a controlled codeine study, hydrocodone first appeared in urine 6 to 11 hours after the dose and peaked at 10 to 18 hours, with concentrations ranging from 32 to 135 ng/mL. The researchers confirmed that the codeine formulation itself contained no hydrocodone contamination; the hydrocodone was genuinely produced through metabolism.
Hydrocodone concentrations were always far lower than codeine concentrations, reaching at most about 11 percent of the parent drug level, and hydrocodone was never detected in a specimen that did not also contain codeine. Still, finding hydrocodone in your urine after taking only Tylenol with Codeine could raise awkward questions during drug testing. The research is clear that minor amounts of hydrocodone alongside high codeine levels should not be taken as evidence of hydrocodone misuse.
Chronic Use Versus a Single Dose
If you have been taking Tylenol with Codeine on a regular schedule rather than a one-time dose, you might assume the drug would accumulate and take much longer to clear. The data suggest otherwise, at least for codeine itself. In a study comparing single-dose and chronic-dose pharmacokinetics in healthy volunteers, the elimination profile of codeine and its primary metabolite codeine-6-glucuronide did not significantly change after repeated dosing. Urinary recovery rates were also similar between single and chronic administration.
That said, chronic use does mean that at any given time there is more total drug in the body simply because you are adding new doses before the previous one has fully cleared. For drug-testing purposes, someone taking Tylenol with Codeine three times a day for a week will have a longer window of detectable metabolites after their last dose compared with someone who took a single tablet, not because clearance is slower but because there is more to clear. Expect an extra day or two on the urine detection window in that scenario, with hair testing reflecting use for months afterward.
Acetaminophen Toxicity and the Liver Connection
Most discussions about how long Tylenol with Codeine stays in the system focus on the codeine component, since that is what drug tests target. But acetaminophen deserves attention for a different reason: liver safety. At normal doses, the liver converts the vast majority of acetaminophen into harmless compounds. A small fraction, however, gets converted by liver enzymes (primarily CYP3A4 and CYP2E1) into a reactive molecule called NAPQI, which can damage liver cells. Under normal circumstances, glutathione neutralizes NAPQI before it causes harm.
The danger arises when acetaminophen intake exceeds the liver’s capacity to detoxify NAPQI, either because the dose is too high, chronic alcohol use has depleted glutathione stores, or another medication is revving up the CYP enzymes that produce NAPQI. For someone on Tylenol with Codeine, this means paying attention to the total daily acetaminophen load, including any other medications that contain acetaminophen (cold medicines, other combination pain relievers). The commonly cited daily ceiling for adults is 3 to 4 grams, but people with liver disease are typically advised to stay well below that.